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Abstract 
This project paper focuses on issues affecting Thera Medic on its delivery 
lead time for supplies of medical devices (surgical products) to public hospitals in 
Malaysia. This paper also aims to provide recommendation to improve the overall 
lead time to meet the lead time expected by the customers. This project paper gives 
an overview of the case issue concerning the current medical devices industry 
scenario as far as supply chain is concerned and challenges being faced by 
manufacturers. In the case analysis part, analytical tools were used to identify root 
cause and gaps in the supply chain process flow. The tools that were applied are, 
cause and effect diagram, supply chain value stream mapping and interview 
questions.  
The root cause reveals several significant root-causes primarily stemming 
from people, process, and material and machines related factors that impact towards 
delivery delays. Focus of this paper addresses primarily the internal factors which 
are controllable and manageable. In contrast, the external factors which primarily 
stems from customers or suppliers are analyzed from risk management approach to 
minimize the risks associated with delivery lead time issues caused by external 
factors. 
To overcome the delivery delays and improve this further, recommendations 
and possible solutions are provided with critical analysis to indicate any 
disadvantages of these risk management plans.
v 
 
 
Executive Summary 
Thera-Medic is a local SME manufacturer of medical devices which 
produces wide range of surgical products in wound care segment. One of the 
challenges faced by Thera Medic is the delivery date requirements from its 
customers, primarily the public hospitals. The fact is that the medical devices has 
non-predictive nature of demand, where the demand fluctuates according to 
healthcare requirements, such as number and timing of surgeries, high mix of 
product range especially the single use devices, lack of planning awareness in 
hospitals and tender or budget dependant purchases. The delivery issues occur 
because of the short lead time required by the hospitals which is around 4 weeks. 
However, the current scenario is that the lead time ranges anywhere between 8 to 21 
weeks which is a huge gap compared to the required delivery date by the hospital. 
The delay in delivering goods has several business implications including 
cancellation of order, credibility of delivery, competitor’s entry, and overall 
customer dissatisfaction.  
The delivery delays are caused by internal and external factors. The external 
factors include customers, suppliers of raw materials and competitors. The internal 
factors concerns the issues stemming from machine, manpower, material, process 
and management. The external factors although are important issues, but these are 
largely beyond control of Thera Medic. The internal factors, however, can be 
managed and controlled to a certain extent. This project paper focuses on issues that 
are considered to be internal factors. In order to derive the improvement plans, first 
the root cause of these delays is analysed using specific tools. The Fishbone diagram 
  
vi 
 
or Ishikawa diagram is used as basis of determining the root cause of these delivery 
delays. The analysis found that several significant factors contribute to the delivery 
delays from manpower, machine, process and equipment. This includes, factors 
stemming from machine downtime, manual process that creates the backlog 
situation, low operator performance, absenteeism among production operators, and 
stock out of raw materials.  
The root cause are also verified and supported by conducting interview with 
the key personnel in the supply chain department. Inputs from these personnel are 
gathered to gain understanding of the supply chain practises which will help to 
formulate the improvement plans. Next tool used to derive the improvement plans 
are the value stream mapping. The objective is to determine gap in the process and 
determine the efficiency in the order processing flow. Analysis shows that the order 
processing involves both manually processed information and information processed 
via a system called AIMS (Accounting and Inventory Management System). The 
manually dine process take relatively longer processing time as these are carried out 
offline using excel spreadsheets, therefore making the ERP system as non-integrated.   
The strategy to improve the lead time falls into two categories, whereby the 
improvement action plans (IAP) are based on internal root-cause are addressed. Each 
category of the root cause from machine, manpower, process and material are 
addressed individually. The external factors are not neglected completely but rather 
taken into consideration by managing the risks associated with external factors. 
These are called risk management plans (RMP) that concerns the issues involving 
primarily the raw material suppliers and customers.  
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The implementation of the IAP and RMP would require a new target lead 
time to be set by management of Thera Medic. As these implementation consumes 
resources and money, a periodic review crucial to ensure its effectiveness and that 
the plans meets its object
1 
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1.0 Introduction 
The supply chain management of medical devices to hospitals are a complex, 
critical and challenging task for all manufacturers and suppliers.  
One of the challenges is able to deliver products within shortest possible time.  
However, the reality is, medical devices supplies are faced with several supply chain 
related issues. Firstly it concerns on its predictive nature of demand of medical 
products. For example, no one can anticipate emergency surgery cases or accidents 
cases that require immediate medical attention and treatment.  This causes planning 
for stocks a challenge for both for the hospitals and also for the manufacturers. In 
addition to this, tenders and budget dependant purchases poses another challenge in 
planning for stocks or forecasting for demand. Tenders usually involves higher 
volumes of purchases and hence the inventory management plays an important role 
to ensure tender supplies are done as per the stipulated delivery deadlines. Another 
challenge especially when it involves high mix products such as the medical 
disposables, the inventory planning is more tedious and risk of having high number 
of slow moving inventory due to the high mix product range if inventory planning is 
not done properly. The other aspects of supply chain of medical devices is that the 
lack of planning awareness among hospital procurement personnel. Hospital 
personnel are more focused on the core responsibilities, which is to save lives and 
ensuring good healthcare services to patients. Therefore, inventory planning is often 
neglected (Raeeda, et al, 2013). This project will focus on analysing the underlying 
factors that contributing to long lead time to supply of surgical products by Thera-
Medic to public hospitals in Malaysia and possible solutions that can be practically 
implemented to improve the lead time.  
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2.0 Current scenario  
Lead time of supply of medical devices (total lead time) currently ranges 
anywhere from 8-21 weeks from the date of order from hospitals. However, most of 
the order from hospital required to be supplied ideally within 4 weeks. This based on 
the required delivery date mentioned in local purchase orders from hospitals (LPO).  
This situation poses several business related risks. One of the major risks is the 
cancellation of order. When orders are cancelled, chances of getting repeat orders 
from customers are compromised and at the same time, the ordered raw materials or 
work in-progress becomes excess liability for the company if not sold to others. In 
addition to this, certain supplies all for penalty if not delivered as per stipulated 
delivery deadline and the company running into risk being blacklisted in the 
particular hospital. The delivery delays ultimately will cause customer dissatisfaction 
and eventually will diminish the company’s credibility and image. When the 
reliability of the supplies becomes an issue, this opens door for competitors to enter 
the hospital and get the orders. This poses a re-entry barrier for Thera-Medic.  
2.1 Industry background  
Healthcare expenditure in Malaysia in 2014 is estimated at RM 42.3 billion 
and continues to grow each year. The healthcare expenditure is on increasing trend 
due to various factors including growing population in which the growth rate is 
approximately 1.3% annually. In 2013, statistics from Ministry of Health shows that 
the crude birth rate per 1,000 population is 17.2% while the crude death rate is at 
4.7% per 1,000 population (Ministry of Health, Health facts). The medical 
device industry is a highly diversified industry that comprises of wide range of 
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products and equipment which includes medical gloves, implantable devices, 
surgical devices and active devices such as in-vitro diagnostic devices (IVD).  
The industry players include many small to medium-sized enterprises 
(SME’s) with certain multinational companies from US and Europe. The industry is 
regarded as capital and technology-intensive. Medical device industry has generated 
employment for more than 20,400 people, from various levels including in the 
managerial levels, professional, supervisory and technical staff levels. Based on 
information obtained from Malaysian Investment Development Authority (MIDA), 
there are more than 180 medical devices manufacturers in Malaysia. By end of 2015, 
it is forecasted that the medical devices marketing Malaysia is expected to reach 
USD 1.69 billion.  
 
Table 1: Medical Device sales indicators in Malaysia, 2009-2015 (Source: 
www.mida.gov.my) 
 
 
In 2013, a total allocation of RM 22.16 billion budget were allocated for 
Ministry of Health which comprises of 141 public hospitals and medical institutes 
and over 2,800 health and community clinics. This allocation accounts for 8.4% of 
the total budget national budget in 2013. (MOH Health Facts, 2014)  
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In line with the increase in healthcare expenditure, the usage of these wound 
closure surgical products in hospitals are increasing every year. The wound closure 
products are generally used whenever any closure of wound is required, either from 
natural causes, for example child birth, or due to external factors such as surgical 
interventions, disease or accidents. In addition to this, more and more competition 
are entering into medical field and the hospitals have more options in selection. 
Based on information obtain from market intelligence of Thera-Medic, there are 3 
active and main supplier of these surgical products that commands more than 50% of 
the market. There are also estimated another 3 to 5 smaller suppliers of these 
products but their market share information are not available as there are relatively 
new to the market and no direct representative offices in Malaysia.  
The healthcare supply chain is often described as highly fragmented and 
inefficient (Schneller and Smeltzer, 2006). Hospitals expect fast delivery of medical 
products and they can’t afford to have “out–of–stock” situation for critical supplies 
of these surgical items in operating theatre. This is more crucial for fast moving 
codes which are used on almost daily basis. The usage of these medical products in 
hospitals is on surgical procedures primarily in general surgery, orthopaedic, 
obstetrics & gynaecology, urology and cardiovascular surgery.  
Given these facts, supplier who is able to deliver the goods within the fastest 
possible time is one of the key success factors, besides than product quality and 
pricing which are also crucial in decision making for purchases.  
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3.0 Company background 
Thera-Medic Sdn. Bhd. is a small medium enterprise (SME) medical device 
manufacturer based in Penang. Established in year 2002, Thera-Medic is involved in 
manufacturing and distribution of medical devices, namely surgical products for 
wound closure, to both government and private hospitals. The company also exports 
to overseas and it has to date more than 12 active export markets. Thera-Medic is 
ISO 13485 certified which is a quality management system for medical devices. In 
addition to this, the products are CE marked and has recently obtained FDA approval 
for one of its range of wound care product. Large portion of its domestic sales are 
concentrated on public (government) hospitals. Thera-Medic also has a local sales 
office in Selangor that handles all the marketing and distribution of the products to 
hospitals throughout Malaysia.  
Being a SME, Thera-Medic has relatively lean organization structure with 
total manpower of 75 people. The organization structure of Thera –Medic is as per 
Figure 1 below.  
 
Figure 1: Organization chart of Thera-Medic 
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The vision of the company is based on principles of being the leader in the 
manufacture and supply of world class medical and surgical devices and with quality 
services. This vision is aimed at developing medical devices which are considered to 
be innovative and at the international quality level. The mission of Thera-Medic is to 
consistently and continually manage quality expectations, innovation and trends, 
human capital development and last but not least, customer satisfaction.  
Main products manufactured by Thera-Medic are categorised into single use surgical 
devices (SUD) that are high mix in nature. The specification of the product varies 
from country to country and even according to hospitals. In single use devices, 
inventory management and delivery lead time plays a crucial role to ensure 
continuous supply without disruption. Therefore, the supply chain that handles the 
delivery and order planning will be the source of primary information for analysis in 
this project. The supply chain department structure in Thera-Medic consists of 
following sub-department and their roles and responsibilities are summarized in the 
job matrix below: 
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Table 2: Job matrix of Supply Chain Department
Section Function Staff details 
Order processing 
and planning 
To receive and process purchase 
orders, maintain contact with 
customers and distributors, prepare 
shipping documents and follow up on 
order status and delivery 
Supply Chain Assistant, 
Officer and Executive 
(headcount : 2)  
Material 
Management 
Receiving and issuance of raw 
material 
Manage inventory and stock accuracy  
Material store Officer, 
Store clerk ( headcount : 2 
) 
Logistics To arrange for inbound and outbound 
transportation to customer and for 
sterilization.  
Supply Chain Officer 
(headcount :1) 
Purchasing To plan for raw material procurement 
and issue purchase order to suppliers 
Purchasing Executive, 
Purchasing Asst. 
(headcount:2) 
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4.0 Case Issue 
The consistency of supply and stock availability of the surgical products are 
crucial in ensuring that the hospital able to carry out the surgical procedures on 
timely manner. The case issue for this paper will be based on delivery information of 
the medical devices to 3 major hospitals in the northern region namely (Hospital 
Seberang Jaya, Hospital Pulau Pinang and Hospital Sultan Abdul Halim, Kedah). 
These 3 hospitals are chosen as they represent approximately 45% of products sold 
within the northern region. Based on information gathered from these 3 major 
hospitals, the supply of disposable medical products is expected within 4 weeks of 
order date for LPO. Exception for this is the tender supplies which are usually 
required on staggered delivery or based on fixed schedule usually over a period of 1 
to 2 years. The required delivery date (RDD) is a challenge as the raw material 
delivery lead time is almost double of that, which ranges around 8-12 weeks. Thera-
Medic manufactures all their products based on orders due to the high variety of the 
devices (exceeding 1,000 article numbers) and considering the shelf life of these 
devices (between 3-5 years). When the product has high variety, it makes stock 
keeping almost quite impossible. Furthermore, the hospital prefers freshly produced 
stocks with shelf life at least 3 years and if Thera-Medic were to keep stock and if 
the stocks did not move for several years, ultimately the remaining shelf life 
becomes less and stocks has to be eventually written off, if its nears its expiry date.  
The main component raw materials for the manufacturing of these surgical 
products are based on steel material and polymer based material. Theses raw 
materials are fully imported as these are medical grade materials which are not 
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available from local suppliers. The tables below gives the simulation of the delivery 
lead time based on 3 give scenarios; finished goods in stock, second scenario if raw 
materials are in stocks and the 3
rd
 scenario if raw materials are not in stock. The 
basis of this simulation is as follows: 
1. Shipping time to local hospitals are around 1 to 2 days via lorry, hence it 
does not gives a major impact on lead time issues which are calculated by 
weeks.  
2. Quantity of order is taken on average for 1 carton of finished goods which is 
132 boxes of surgical devices.  
3. No backlog, quality issue or machine downtime in production. 
4. Production are based on first in first out (FIFO) to consider 4 weeks lead 
time.  
5. Production capacity is available  
Scenario #1:  Finished goods in stock 
Required 
Delivery date 
(RDD) 
Raw Material lead 
time (average)  
Production Time 
(average) 
Total Lead time 
(TLT)  (average)  
Difference 
between RDD 
and TLT 
4 weeks from 
order date 
Not applicable Not applicable 1 – 2 days  0 weeks  
Scenario #2: If raw materials are IN stock  
Required 
Delivery date 
(RDD) 
Raw Material 
lead time 
(average)  
Production Time 
(average) 
Total Lead time 
(TLT) (average)  
Difference 
between RDD 
and TLT 
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4 weeks from 
order date 
Not applicable 4 weeks  4 weeks 0 weeks  
Scenario #3: If raw materials are NOT in stock.  
Required 
Delivery date 
(RDD) 
Raw Material 
lead time 
(average)  
Production 
Time (average) 
Total Lead 
time (TLT)  
(average)  
Difference 
between RDD 
and TLT 
4 weeks from 
order date 
10 weeks 4 weeks 14 weeks 10 weeks 
 
Based on the simulation of the lead time above, it is clear that the lead time 
for delivery to hospital can range anywhere between 1 day to 14 weeks which is a 
huge gap. Therefore, in priority, Thera-Medic need to address scenario 3 as scenario 
2 is still manageable within the given required delivery date by the hospital which is 
4 weeks. Scenario 3 gives a delivery delay of 10 weeks. The second level priority 
will be to address scenario 2 in managing risk in case raw materials in stock has 
quality issues or unanticipated shortages (discrepancies in stock count, misallocation 
to other customers). 
To verify this situation further, an analysis is carried out on top 10 commonly sold 
surgical products to hospitals. The top 10 common codes contribute to 40% of 
overall sales of the surgical products. Table 3 indicates the summary of the Total 
Lead Time (TLT) for the top 10 codes and the comparison against the required 
delivery date based on data collected from January 2014 to December 2014
:
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Table 3: Total lead time analysis for top 10 common codes 
Article Number 
Total Lead Time 
(TLT) (weeks)  
Required delivery 
date (RDD) 
(weeks) 
Delay (weeks) 
F2 20.7 4 16.7 
B3 18.2 4 14.2 
E1 12.0 4 8.0 
B4 10.1 4 6.1 
S2 9.7 4 5.7 
B2 11.4 4 7.4 
C2 10.7 4 6.7 
B5 7.6 4 3.6 
E8 9.4 4 5.4 
P4 14.5 4 10.5 
MIN 7.6 4.0 3.6 
MAX 20.7 4.0 16.7 
AVERAGE 12.4 4.0 8.4 
 
The average lead time of the supply is around 12.4 weeks. On average, the 
delay is approximately 8.4 weeks of delay if considering 4 weeks required delivery 
date (RDD) from customer and the difference are significant which could affect the 
business of Thera-Medic. 
 
 
 
  
12 
 
 
4.1 Business implications on delivery delay  
There are several business implications as a result of the delivery delays : 
a. Cancellation of order  
When goods are not delivered on the required delivery date of customer 
(RDD), there are high risk chances that the order might be cancelled by the 
hospitals. Hospitals can’t afford to run out of stocks of surgical products and 
in such cases, they will turn to other suppliers who can supply the similar 
specifications of the surgical products. At the same time, the goods which are 
probably half way through in production or raw materials which are on 
transit, but have to be kept as stocks or allocate to other customers, if at all 
there is an order for similar item. In any case, this may also cause excess 
stock at Thera-Medic.  
 
b. Image and credibility of the company affected 
When order gets cancelled, the credibility of future supplies from Thera-
Medic will be affected. This makes a major impact on future order decisions 
from the hospitals, more so if the delays are frequent. Hence, it’s imperative 
that the issue of delivery lead time must be addressed in order to ensure 
continues orders from the hospital.  
c. Customer dissatisfaction 
Delivery delays do affect customer satisfaction significantly. Customer 
considers delivery commitment from suppliers are measure of a service 
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quality. When service quality is not met according to what the customer 
require, customer will be dissatisfied and affects the sustainability of the 
business in a particular hospital.  
d. Opportunity for competitors  
As explained earlier, customers nowadays have options due to emergence of 
new competitors in the field of medical device supplies. Hence, any customer 
who are dissatisfied will turn to new suppliers and this is paving way for new 
players to establish account with the hospital. This directly creates another re-
entry barrier for suppliers who have been already supplying before.  
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5.0 Tools for case analysis 
The focus of the analysis in the project paper will based on internal issues 
that contributing to the delivery lead time issues. This includes factors such as 
production and manpower efficiency, inventory management and other internal 
system factors. The external factors on customers and suppliers are excluded in this 
analysis as the extents of control of these external factors are minimal. Nevertheless, 
certain recommendations are given in the recommendations sections as to 
suggestions to address customers and suppliers issues to minimise or manage 
external factors risks.  
To analyse the case issue further from the internal point of view, several 
method of analysis will be used in this project. The background and objective for 
applying these tools are as described as per following:   
5.1 Fishbone analysis 
 Fish bone analysis or popularly known as Ishikawa diagram or “cause and 
effect diagram” is a tool for analysing cause and effect of a specific issue. Although 
this tool is originated from quality defect prevention, the supply chain issues can also 
be can be also analysed using this tool. This tool is chosen in particular to analyse 
contributing or potential factors that leads to overall effect of delivery lead time 
issues as it is able to view the issues from various aspects from material to even 
environment. The segment of factors that will be considered in this analysis are 
based on people based factors, machine factors, method, material, management and 
environment 
5
.  
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Figure 2: Cause and effect diagram template 
 
The source of data that will be collected and analysed will be in the 
form of: 
i. Order trend data from key hospitals for the top 10 common 
codes  
ii. Historical data on delivery lead time  
iii. Production lead time information 
iv. Frequency of on-time delivery versus delay in deliveries 
v. Raw material lead time of the common codes 
vi. Order processing time and production loading performance 
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5.2 Value Stream Mapping on Supply Chain  
This is useful analytical tool for lean management and identifies any non-value 
added activity or unproductive activity along the various stages in supply chain. This 
is generally a process activity mapping that will help Thera-Medic to study the flow 
of process that enables segregation of each critical steps, identify any waste or non-
value-added activity along the process and finally can be used as a tool to re-arrange 
the sequence in a more effective manner to be leaner. The Value Stream mapping in 
this project is applied throughout the order processing steps that starts from the 
receipt of order from customer, until delivery is made. Each step involved in the step 
is analysed in terms of the duration taken and determination whether the process is 
done via system or manually. 
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6.0 Interview and questionnaire 
In order to obtain feedback from various internal people that has direct influences in 
the delivery lead time, an interview session were conducted. The set of questions that 
are posed to the interviewees are unique, and has combination of questions that is 
able to lead to the contributing factor for the lead time issues. The target group for 
the questions are  
a. Supply chain executives and officers 
b. Purchasing executive and materials management personnel 
c. Production Executive 
The interview plan are summarised as per Table 4.  
 
Table 4: Interview plan 
Person to be interviewed Objective 
Supply Chain Officer 
Supply Chain Executive 
To identify the KPI’s, challenges faced in supply 
chain concerning delivery and how it’s being 
managed 
Purchasing executive 
Material management 
To identify existing inventory management 
process and production planning 
Production Executive 
To understand about the overall production 
performance from process, machine and 
manpower that affecting production lead time.  
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Following are the list of questions that will be included in the interview 
session 
 
 
 
1. Supply Chain Officer/Executive : 
 How many PO do you receive in a month (on average) 
 How long it takes (on average) to produce goods from date of order? 
 Does all your customer provides forecast or rolling forecast? 
 How often are you able to meet customer's required date? 
 Have you experienced order cancellation due to delivery delays? 
 Have you experienced order cancellation due to delivery delays? 
 Do you perform customer satisfaction surveys? 
 Do you calculate and analyse delivery lead time for each orders? 
 What is your delivery performance targets (KPI's?) 
 Did you meet those targets? 
 What are the patterns of customer orders? 
 What are the reason you are not able to meet delivery lead time? 
 How do you manage urgent/ unexpected orders? 
 
2. Purchasing and Materials Management 
 How long it takes to do material planning for new orders 
 What system do you use for material planning? 
 What is average number of loading (shop floor) per month? 
 What issue you face for material planning? 
 What issue you face for material planning? 
 Do you maintain safety stock level? 
 Do you maintain reorder level? 
 How do you manage late deliveries from vendor? 
 How do you manage stock discrepancy issues? 
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 What is your loading performance targets (KPI's?) 
 Did you meet those targets? 
 How often do you experience stock out situation for critical items? 
 How do you manage urgent/ unexpected orders? 
 
 
3. Production Executive 
 What is your current capacity utilization? 
 How often you face capacity issue(s) in a month?  
 What is your KPI for operator performance? 
 What is your average production lead time? 
 What contributes to delay in production? 
 What is your major manpower issue? 
 How do you manage urgent orders? 
 What is the average machine downtime per day? 
 Which area has more machine downtime? 
 How often do you face material quality issue in a month? 
 Do you face downtime due to material shortages? 
 
The feedback from these questions will be analysed as inputs into Case and Effect 
diagram, and Supply Chain Value Stream Mapping analysis.  
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7.0 Case Analysis 
In all these 3 category of people that are involved in the supply chain, the 
customer and suppliers are categorised as external factors that are not within a direct 
control of Thera-Medic. This is due to the fact that the delivery delays of raw 
materials from vendors is beyond the control of Thera-Medic. Likewise, customers 
that are not able to provide advance orders or forecasts are beyond the control of 
Thera-Medic. On the other hand, the factors arising from manufacturer itself can be 
controlled and managed. Hence, the internal factors will be more discussed in detail 
as the internal factors can be controlled and managed by Thera-Medic. The external 
factor, however, will be taken into consideration using the risk management 
approach which is addressed in section 8.2.  
7.1 Cause and Effect analysis 
In order to determine the cause or factors that contribute to delivery lead time, a 
fishbone analysis or well known as Ishikawa or cause and effect diagram is used to 
identify the various contributing factors. In this analysis, 6 main areas are analysed 
in particular, equipment, process, people, materials, environment and management. 
These factors are analysed from the internal activities within Thera-Medic.  
a. Equipment or Machine downtime 
The equipment that is used in the manufacturing comprises of mechanical or 
pneumatic-PLC based assembly machine, packaging machine and sterilization 
machines. The front end manufacturing process are either manual or semi-
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automated, while the back end process can be considered to be automated 
process. Given this scenario, the manual operations may potentially contribute to 
increase in production lead time as the process is human dependant. The standard 
production lead time, considering a quantity of 132 boxes is about 4 weeks. 
Assuming that there is no machinery breakdown, no production backlog or any 
capacity constraint issue, the production lead time can be described per Figure 3 
below:  
 
 
 
 
Figure 3: Lead time of back end and front end of production process 
 
As described in Figure 3, the back end process are automated which are machine 
dependent. The packaging machine and sterilization process could be potentially 
contributing completion of production of orders to extend beyond 2 weeks if there is 
machine downtime. Following are the more in-depth analysis of the downtime 
occurred in the back end process from January to December 2014. These are 
downtime data which has been recorded on daily basis and then compiled on 
monthly basis for analysis.  The impact of the machine downtime on the delivery 
delays are calculated based on following formula: 
Production lead time delay (in days) = total machine downtime (hours)  per month / 
8 hours 
FRONT  END 
(assembly)  
2 weeks 
BACK END  
(packaging and sterilization) 
2 weeks 
FINISHED 
GOODS 
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The 8 hours represents the normal production hours per day (Thera-Medic currently 
does not operates on shift basis) 
  
Table 5: Machine downtime impact on delivery delays 
Month Downtime (hours) 
Delay impact on production 
lead time (days) 
JAN 13.40 1.68 
FEB 4.55 0.57 
MAR 34.50 4.31 
APR 54.40 6.80 
MAY 39.25 4.91 
JUN 17.30 2.16 
JUL 69.55 8.69 
AUG 8.35 1.04 
SEP 33.15 4.14 
OCT 40.15 5.02 
NOV 103.55 12.94 
DEC 21.00 2.63 
MIN 4.55 0.57 
MAX 103.55 12.94 
AVERAGE 36.60 4.57 
 
 
As per above analysis, the average number of days the production lead time 
delay is approximately 4.6 days, while the highest recorded delay was approximately 
13 days. The downtime recorded in July (8.69 days) and November (13 days) were 
almost twice and three times higher than the average due to the back end machine 
breakdown in which the production was dependent on single machine. This shows 
that the machine downtime plays a crucial role in influencing the total delivery lead 
time.  
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b. Process 
i. Production process 
Production process plays an important role in determining the overall lead time, 
especially the type of production process involved, whether the process is manual 
(human dependent) or automated (machine dependent). The process factor is further 
analyzed from process point of view than can lead to delivery issues are the backlog 
occurring due to bottleneck situation. The bottleneck situation occurs primarily due 
to capacity related issue whereby a succeeding step has lower output per hour than 
the preceding step. This is to say, for example process B has lower output than 
process A. Hence, potential bottleneck situation can occur at step B. Hence, the 
sequence of steps throughout the production process is analyzed to check if any 
significant bottle neck situation that could potentially contribute to delivery delays.  
The front end process is a manpower dependent process whereby many 
manually carried out process taking place especially in the assembly section. In order 
to investigate this issue further, the key parameter used is the output per day analysis 
in order to determine if there are any potential backlogs that can be created. Table 6 
shows the average output per day on various steps of front end production versus the 
back end process. The front end process has 3 assembly stages while the back end 
process has 3 processing stages which are described in Table 6. 
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Table 6: Production capacity on various stages of process 
 
Process ID Capacity per day (pcs) 
Stage 
LC 15,000 
Front end 
 NA 11,000 
WD 12,000 
PP 15,000 
Back end 
SP 17,000 
FS 16,000 
 
 
Figure 4: Capacity analysis of various production stages 
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